https://orcid.org/0000-0002-0976-781X
References
- O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Am J Obstet Gynecol. 2016;214(1):103.e1–103.e12.
- O’Gorman N, Nicolaides KH, Poon LC. The use of ultrasound and other markers for early detection of preeclampsia. Womens Health (Lond). 2016;12(2):199–207.
- O’Gorman N, Wright D, Poon LC, et al. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756–760.
- Plasencia W, Maiz N, Bonino S, et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of preeclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742–749.
- Lovgren TR, Dugoff L, Galan HL. Uterine artery Doppler and prediction of preeclampsia. Clin Obstet Gynecol. 2010;53(4):888–898.
- Khong SL, Kane SC, Brennecke SP, et al. First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis Markers. 2015;2015:article ID 679730, 10 pages. DOI:10.1155/2015/679730
- Costa AGD, Spara P, Costa TDO, et al. Índices de resistência e pulsatilidade das artérias uterinas no primeiro e segundo trimestres de gestações normais Radiol Bras. 2010;43(3):161–165.
- Drouin O, Johnson JA, Chaemsaithong P, et al. Transverse technique: complementary approach to measurement of first-trimester uterine artery Doppler. Ultrasound Obstet Gynecol. 2018;52(5):639–647.
- CLINICAL OVERVIEW. Preeclampsia and eclampsia. Elsevier Point Care. 9 August, 2017.
- Campbell S, Diaz-Recasens J, Griffin DR, et al. New Doppler technique for assessing uteroplacental blood flow. Lancet. 1983;1(8326 Pt 1):675–677.